Mithat Gönen
Mithat Gönen
Memorial Sloan-Kettering Cancer Center
Dirección de correo verificada de - Página principal
Citado por
Citado por
Assessing the performance of prediction models: a framework for some traditional and novel measures
EW Steyerberg, AJ Vickers, NR Cook, T Gerds, M Gonen, N Obuchowski, ...
Epidemiology (Cambridge, Mass.) 21 (1), 128, 2010
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade
WR Jarnagin, M Gonen, Y Fong, RP DeMatteo, L Ben-Porat, S Little, ...
Annals of surgery 236 (4), 397, 2002
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
ML Davila, I Riviere, X Wang, S Bartido, J Park, K Curran, SS Chung, ...
Science translational medicine 6 (224), 224ra25-224ra25, 2014
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
JP Patel, M Gönen, ME Figueroa, H Fernandez, Z Sun, J Racevskis, ...
New England Journal of Medicine 366 (12), 1079-1089, 2012
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma
WR Jarnagin, Y Fong, RP DeMatteo, M Gonen, EC Burke, J Bodniewicz, ...
Annals of surgery 234 (4), 507, 2001
Actual 10-year survival after resection of colorectal liver metastases defines cure
JS Tomlinson, WR Jarnagin, RP DeMatteo, Y Fong, P Kornprat, M Gonen, ...
Journal of Clinical Oncology 25 (29), 4575-4580, 2007
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24 stem cell–like breast cancer cells in human tumors
LLC Marotta, V Almendro, A Marusyk, M Shipitsin, J Schemme, SR Walker, ...
The Journal of clinical investigation 121 (7), 2723-2735, 2011
Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify …
RM Tuttle, H Tala, J Shah, R Leboeuf, R Ghossein, M Gonen, M Brokhin, ...
Thyroid 20 (12), 1341-1349, 2010
Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia
JH Park, I Rivière, M Gonen, X Wang, B Sénéchal, KJ Curran, C Sauter, ...
New England Journal of Medicine 378 (5), 449-459, 2018
Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection
I Endo, M Gonen, AC Yopp, KM Dalal, Q Zhou, D Klimstra, M D'Angelica, ...
Annals of surgery 248 (1), 84-96, 2008
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases
DA Kooby, J Stockman, L Ben-Porat, M Gonen, WR Jarnagin, ...
Annals of surgery 237 (6), 860, 2003
Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning
RJ Robbins, Q Wan, RK Grewal, R Reibke, M Gonen, HW Strauss, ...
The Journal of Clinical Endocrinology & Metabolism 91 (2), 498-505, 2006
Patterns of initial recurrence in completely resected gastric adenocarcinoma
M D'Angelica, M Gonen, MF Brennan, AD Turnbull, M Bains, MS Karpeh
Annals of surgery 240 (5), 808, 2004
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
L Busque, JP Patel, ME Figueroa, A Vasanthakumar, S Provost, ...
Nature genetics 44 (11), 1179, 2012
Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
RP DeMatteo, JS Gold, L Saran, M Gönen, KH Liau, RG Maki, S Singer, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
J Eyquem, J Mansilla-Soto, T Giavridis, SJC van der Stegen, M Hamieh, ...
Nature 543 (7643), 113-117, 2017
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study
LB Saltz, HJ Lenz, HL Kindler, HS Hochster, S Wadler, PM Hoff, ...
Journal of Clinical Oncology 25 (29), 4557-4561, 2007
Concordance probability and discriminatory power in proportional hazards regression
M Gönen, G Heller
Biometrika 92 (4), 965-970, 2005
Intensity of 18Fluorodeoxyglucose Uptake in Positron Emission Tomography Distinguishes Between Indolent and Aggressive Non-Hodgkin’s Lymphoma
H Schöder, A Noy, M Gönen, L Weng, D Green, YE Erdi, SM Larson, ...
Journal of Clinical Oncology 23 (21), 4643-4651, 2005
Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection
M Shoup, M Gonen, M D’Angelica, WR Farnagin, RP DeMatteo, ...
Journal of gastrointestinal surgery 7 (3), 325-330, 2003
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20